3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
4
Rectal Neoplasms
2
Neoplasms
2
Gastrointestinal Stromal Tumors
2
Solid Malignant Tumors
1
Sarcoma, Ewing
1
Sarcoma
1
Recurrence
1
Piebaldism
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Glioblastoma
1
Disease Progression
1
Cholangiocarcinoma
1
Bone Neoplasms
1
Interventions
Specimen Handling
5
Nivolumab
5
Magnetic Resonance Spectroscopy
4
pembrolizumab
3
Biopsy
3
dehydroftorafur
2
Sigmoidoscopy
2
Radiotherapy, Intensity-Modulated
2
Proctoscopy
2
Paclitaxel
2
Mitozytrex
2
Mitomycin
2
Fluorouracil
2
Fluorodeoxyglucose F18
2
Colonoscopy
2
Carboplatin
2
Capecitabine
2
trastuzumab deruxtecan
1
entinostat
1
bintrafusp alfa protein, human
1
X-Rays
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Taxes
1
Surveys and Questionnaires
1
Sentinel Lymph Node Biopsy
1
Radiotherapy
1
Radionuclide Imaging
1
Radiation
1
Phantoms, Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
regorafenib
×
90 days
×
Clear all
No trials found.